Q4 2025 AVITA Medical Inc Earnings Call Transcript
Key Points
- AVITA Medical Inc (AVHHL) reported a full year revenue of approximately $71.6 million, representing an 11% growth over 2024.
- The company has resolved reimbursement uncertainty with 6 out of 7 Medicare administrative contractors publishing payment rates for resale procedures.
- AVITA Medical Inc (AVHHL) has aligned sales incentives and field activity around earlier adoption and repeat use within core accounts, enhancing predictability and utilization.
- The company has a strong gross margin of 82.1% for the full year, providing a solid foundation for future growth.
- AVITA Medical Inc (AVHHL) has refinanced its debt through a new credit facility, reducing restrictive covenants and improving financial flexibility.
- Fourth quarter revenue was $17.6 million, a decrease from $18.4 million in the prior year period.
- The gross margin for the fourth quarter decreased to 81.2% from 87.6% in the same period last year, driven by inventory reserves and product mix.
- Operating expenses in the fourth quarter were $24.7 million, including $1.2 million of one-time severance costs.
- The company ended the quarter with $18.2 million in cash and marketable securities, indicating limited cash reserves.
- The seventh Medicare administrative contractor has not yet published payment rates, which could impact reimbursement clarity.
Good day and thank you for standing by. Welcome to the Avida Medical Inc. 4th quarter and full year 2025 earnings conference call. At this time, all participants are in listen-only mode. After the speaker's presentation, there'll be a question-and-answer session.
To ask a question during the session, you'll need to press 11 on your telephone. You will then hear automated message advising your hand is raised. To withdraw your question, please press 11 again. Please advise that today's conference is being recorded. All right then, conference over to your first speaker today, Ben Atkins. Please go ahead.
Thank you, operator.
Welcome to Avita Medical's fourth quarter and full year 2025 earnings call.
Joining me on today's call are Carrie Vance, interim Chief Executive Officer, and David O'Toole, Chief Financial Officer.
Today's earnings release and presentation are available on our website at
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
